In a major milestone for diabetes management, India has become one of the first countries globally to introduce Awiqli, the world’s first once-a-week basal insulin...
AstraZeneca announced positive results from the VISTA and SOLSTICE Phase IIb trials of elecoglipron, an investigational oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA). The data,...
Dr. Reddy’s Laboratories has announced the launch of Obeda®, its oral semaglutide tablet for the treatment of Type 2 diabetes in India. The once-daily tablet...